Preventing intrahepatic infection after ablation of liver tumours in biliary-enteric anastomosis patients
Authors:
- 28 February 2017
- journal article
- research article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 33 (6) , 664-669
Abstract
Purpose: To assess the value of bowel preparation plus targeted antibiotics for preventing intrahepatic infections after MWA of liver tumours in BEA patients. Materials and methods: This retrospective study included 21 patients (divided into two groups) with a history of BEA undergoing ultrasound-guided MWA of liver tumours from November 2008 to June 2014. Group A (n = 10) received single-antibiotic therapy (cefazedone 2 g bid 4, amoxicillin and flucloxacillin sodium 2 g bid 3, levofloxacin 0.5 g qd 3) after ablation, and group B (n = 11) received bowel preparation before ablation plus combined antibiotic therapy (imipenem and cilastatin sodium 1 g 1/12 h, linezolid 0.6 g 1/12 h). Patients were followed for 3 months. Incidences of fever, bacteraemia, and intrahepatic infections were compared, including the duration of fever and length of hospital stay. Results: Following ablation, in group A, 90% of the patients (9/10) had fever, 60% (6/10) had bacteraemia, 60% (6/10) had liver abscess, and 10% (1/10) had biliary tract infection. In group B, no cases of bacteraemia or intrahepatic infection were reported, and the incidences of fever, bacteraemia, and liver abscess were substantially lower than group A (p = 0.002, 0.004, 0.004). Duration of fever and length of hospital stay were markedly shorter than group A (p = 0.002 0.003). Conclusions: Bowel preparation plus targeted antibiotic therapy can significantly reduce the incidences of fever, bacteraemia, and intrahepatic infections in BEA patients undergoing MWA of liver tumours. These preliminary results need to be further validated in randomised trials.Keywords
Funding Information
- National Natural Science Foundation of China (81671710)
- National Natural Science Foundation of China (81471683)
This publication has 28 references indexed in Scilit:
- Status and advancement of microwave ablation in ChinaInternational Journal of Hyperthermia, 2016
- Multimodality treatment of recurrent pancreatic cancer: Mith or reality?World Journal of Gastrointestinal Oncology, 2015
- Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancyWorld Journal of Gastroenterology, 2013
- International multicentre prospective study on microwave ablation of liver tumours: preliminary resultsHPB, 2011
- Microwave ablation for unresectable hepatic tumours: Clinical results using a novel microwave probe and generatorEuropean Journal of Surgical Oncology, 2010
- Safety and Efficacy of Microwave Ablation of Hepatic Tumors: A Prospective Review of a 5-Year ExperienceAnnals of Surgical Oncology, 2009
- Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic reviewEuropean Journal of Gastroenterology & Hepatology, 2009
- Adjuvant chemo-radiotherapy in ampullary cancersEuropean Journal of Surgical Oncology, 2005
- Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?Cancer, 2002
- Recurrence after resection for ductal adenocarcinoma of the pancreasWorld Journal of Surgery, 1997